EPISODE · Dec 19, 2024 · 12 MIN
Peds RAP - Nirsevimab: The Latest Tool to Prevent RSV
from Hippo Education Presents: The Monthly Rounds
Nirsevimab - the new RSV monoclonal antibody has been FDA approved for use in infants. Parul and Sol review what it is, how effective it is in preventing severe RSV bronchiolitis, and who should receive it. Explore Our Podcasts: hippoed.com/podcasts
NOW PLAYING
Peds RAP - Nirsevimab: The Latest Tool to Prevent RSV
No transcript for this episode yet
Similar Episodes
Mar 26, 2026 ·1m
Mar 19, 2026 ·34m
Feb 18, 2026 ·11m
Feb 11, 2026 ·45m